These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23826301)

  • 1. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
    Baum E; Randall AZ; Zeller M; Barbour AG
    PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
    Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
    Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
    Earnhart CG; Buckles EL; Dumler JS; Marconi RT
    Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Anti-
    Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H
    Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
    Wilske B; Jauris-Heipke S; Lobentanzer R; Pradel I; Preac-Mursic V; Rössler D; Soutschek E; Johnson RC
    J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
    Yang X; Li Y; Dunn JJ; Luft BJ
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
    Buckles EL; Earnhart CG; Marconi RT
    Clin Vaccine Immunol; 2006 Oct; 13(10):1162-5. PubMed ID: 17028218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
    Jobe DA; Lovrich SD; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
    Jacquet M; Durand J; Rais O; Voordouw MJ
    Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice.
    Krupka M; Masek J; Barkocziova L; Turanek Knotigova P; Kulich P; Plockova J; Lukac R; Bartheldyova E; Koudelka S; Chaloupkova R; Sebela M; Zyka D; Droz L; Effenberg R; Ledvina M; Miller AD; Turanek J; Raska M
    PLoS One; 2016; 11(2):e0148497. PubMed ID: 26848589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
    Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
    J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Izac JR; O'Bier NS; Oliver LD; Camire AC; Earnhart CG; LeBlanc Rhodes DV; Young BF; Parnham SR; Davies C; Marconi RT
    Vaccine; 2020 Feb; 38(8):1915-1924. PubMed ID: 31959423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of antibody responses to Borrelia burgdorferi in experimentally infected beagle dogs.
    Baum E; Grosenbaugh DA; Barbour AG
    Clin Vaccine Immunol; 2014 Jun; 21(6):838-46. PubMed ID: 24695775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR; Oliver LD; Earnhart CG; Marconi RT
    Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous
    Pfeifle A; Zhang W; Cao J; Thulasi Raman SN; Anderson-Duvall R; Tamming L; Gravel C; Coatsworth H; Chen W; Johnston MJW; Sauve S; Rosu-Myles M; Wang L; Li X
    Emerg Microbes Infect; 2024 Dec; 13(1):2399949. PubMed ID: 39221484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.